Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Menactra Approval Awaits Final Manufacturing Clearance

This article was originally published in The Pink Sheet Daily

Executive Summary

Sanofi-Aventis says it is prepared to produce a limited supply of the meningococcal conjugate vaccine soon after licensure. To meet expanded demand, the company is constructing a new Menactra manufacturing facility that will be fully operational in two to three years.
Advertisement

Related Content

Menactra Launch Slated For March On Heels Of Broad CDC Recommendations
Menactra Launch Slated For March On Heels Of Broad CDC Recommendations
Menactra Pricing Will Be In Line With Wyeth's Prevnar, Sanofi-Aventis Says
Menactra Pricing Will Be In Line With Wyeth's Prevnar, Sanofi-Aventis Says
Sanofi-Aventis Eyes Expanded Menactra Indication Following Initial Approval
Sanofi-Aventis Eyes Expanded Menactra Indication Following Initial Approval
Chiron Halts Menjugate Meningococcal Vaccine Program After Pivotal Trials
Where’s Menactra? No Word From Sanofi-Aventis As User Fee Date Passes
Where’s Menactra? No Word From Sanofi-Aventis As User Fee Date Passes
Sanofi-Aventis' Menactra Post-Approval Commitments Should Include Long-Term Safety, Efficacy Data

Topics

Advertisement
UsernamePublicRestriction

Register

PS058201

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel